Familiar Therapeutics
PrivateLast Round
Seed
Oct 22, 2026
Total Funding Raised
$5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Familiar Therapeutics operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Seed round in October 2026.
Familiar Therapeutics is a biotechnology company that develops veterinary therapeutics and companion diagnostics by translating proven human drug candidates into novel treatments for companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Familiar Therapeutics Comparables
Compare Familiar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vetbiolix | 81% | |
| Anivive Lifesciences | 81% | |
| Vetigenics Inc. | 80% |
For institutional investors. Book with your work email.
Familiar Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Familiar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Icehouse Ventures | Seed |
| Pioneer Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$5M round led by Pioneer Fund and Icehouse Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 23, 2026
Familiar raises a $5M Seed round led by Pioneer Fund, Icehouse Ventures, and BreakTHRU, alongside angel investors, to support its lead clinical programs and pipeline development in California on Oct 21st '26.
For institutional investors. Book with your work email.
Familiar Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Familiar Therapeutics's valuation, stock price, and market status.
Is Familiar Therapeutics a public or private company?
Familiar Therapeutics is a private company.
What is the current stock price of Familiar Therapeutics?
Familiar Therapeutics is a private company, so its shares have no public market price. Caplight tracks Familiar Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Familiar Therapeutics worth (valuation)?
Valuation information for Familiar Therapeutics is not publicly available.
Can I buy Familiar Therapeutics stock?
Familiar Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Familiar Therapeutics's last funding round?
Familiar Therapeutics's most recent funding round was Seed on October 22, 2026.
Who are the main investors in Familiar Therapeutics?
Key investors in Familiar Therapeutics include Icehouse Ventures, Pioneer Fund.
Will Familiar Therapeutics IPO soon?
No public IPO plans have been announced for Familiar Therapeutics.
How can I track Familiar Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Familiar Therapeutics's shares on secondary markets.